Meitz, J C <br/><br/>
HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.  [electronic resource] 

 -  British journal of cancer  Oct 2002 
 - 905-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6600564  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age of Onset<br/>Aged<br/>Aged, 80 and over<br/>Case-Control Studies<br/>DNA--blood<br/>DNA, Neoplasm--metabolism<br/>Female<br/>Genetic Predisposition to Disease--genetics<br/>Genetic Variation--genetics<br/>Genotype<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation--genetics<br/>Neoplasm Proteins--genetics<br/>Odds Ratio<br/>Polymorphism, Genetic<br/>Prostatic Neoplasms--genetics<br/>Risk Factors